GO:0045655 regulation of monocyte differentiation: Signaling Networks, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0045655 (regulation of monocyte differentiation) covers any process that modulates the frequency, rate or extent of monocyte differentiation, a biological_process node in the Gene Ontology.
Monocyte differentiation is controlled by specific signaling modules and associated transcription factor networks, including MafB, ETV3 and ETV6.
Local monocyte proliferation restricted by MafB precedes lung interstitial macrophage differentiation, linking cell-cycle control to differentiation fate.
Tumor-derived retinoic acid reprograms intratumoral monocyte differentiation to promote immune suppression, showing that the tumor microenvironment regulates this process.
PAQR11 modulates monocyte-to-macrophage differentiation and contributes to rheumatoid arthritis pathogenesis.
Non-coding RNA layers, including microRNAs and tRNA-derived short RNAs, regulate activation-associated accumulation and macrophage survival during monocyte differentiation.

Description

Monocytes are circulating innate immune cells that differentiate into macrophages and dendritic cells, and the Gene Ontology term GO:0045655 (regulation of monocyte differentiation) describes any process that modulates the frequency, rate or extent of this differentiation event. Because monocyte differentiation sits at the crossroads of inflammation, tissue repair and immune surveillance, its regulation is a central question in immunology and hematology. The process is not a single switch but a coordinated program driven by specific signaling modules and associated transcription factor networks that interpret extracellular cues and impose lineage-specific gene expression. Research over the past decade has shown that regulation of monocyte differentiation involves transcription factors such as MafB, ETV3 and ETV6, which restrict alternative fates and enable dendritic cell or macrophage commitment. Tumor-derived retinoic acid can redirect intratumoral monocyte differentiation toward immunosuppressive states, demonstrating that the microenvironment is a potent regulator of this process. Metabolic and membrane-associated regulators, including PAQR11, further modulate monocyte-to-macrophage differentiation and disease pathogenesis. At the post-transcriptional level, microRNAs and tRNA-derived short non-coding RNAs accumulate in a regulated manner during monocyte-to-macrophage differentiation and influence macrophage survival. HLA-E trafficking is also regulated during monocyte-macrophage differentiation, linking antigen-presentation machinery to the differentiation program. Together, these findings define GO:0045655 as an integrative process that coordinates signaling, transcription, non-coding RNA networks and intracellular trafficking.

regulation of monocyte differentiation At A Glance

GO ID GO:0045655
GO term regulation of monocyte differentiation
Ontology biological_process
Synonym None listed in QuickGO
Major function Modulates the frequency, rate or extent of monocyte differentiation
Key transcription factors MafB, ETV3, ETV6
Key signaling/microenvironment inputs Specific signaling modules, tumor-derived retinoic acid
Non-coding RNA regulators microRNAs, tRNA-derived short non-coding RNAs
Disease relevance Rheumatoid arthritis, tumor immune suppression

What Is GO:0045655?

GO:0045655 (regulation of monocyte differentiation) is a biological_process term defined as any process that modulates the frequency, rate or extent of monocyte differentiation. In practical terms, it includes the signaling modules, transcription factor networks, non-coding RNA circuits and metabolic regulators that decide whether a monocyte precursor commits to, accelerates, slows or diverts its differentiation into a mature monocyte or a downstream macrophage/dendritic cell fate.

Why Is regulation of monocyte differentiation Important in Cell Biology?

Regulation of monocyte differentiation (GO:0045655) is important because monocytes are the principal circulating precursors of macrophages and dendritic cells, and the balance between these fates shapes inflammation, tissue homeostasis and anti-tumor immunity. When this regulation is perturbed, monocytes can adopt immunosuppressive or pathogenic states, as shown by tumor-derived retinoic acid driving intratumoral monocyte differentiation toward immune suppression and by PAQR11 modulating monocyte-to-macrophage differentiation in rheumatoid arthritis. Understanding the signaling modules and transcription factor networks that control this process therefore has direct implications for cancer immunotherapy, autoimmune disease and regenerative medicine.
Defines how extracellular signals are converted into monocyte fate decisions through specific signaling modules and transcription factor networks.
MafB-restricted local monocyte proliferation is a prerequisite for lung interstitial macrophage differentiation, linking proliferation control to differentiation.
Tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression, a mechanism relevant to cancer immunotherapy.
PAQR11 modulates monocyte-to-macrophage differentiation and the pathogenesis of rheumatoid arthritis.
HLA-E regulation and trafficking during monocyte-macrophage differentiation connect the process to antigen presentation.
Activation-associated microRNA accumulation rates are regulated during monocyte-to-macrophage differentiation.
tRNA-derived short non-coding RNAs profile changes during monocyte differentiation and influence macrophage survival.
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment.
Provides a framework for identifying therapeutic targets in inflammatory and autoimmune diseases.
Supports the design of CRISPR-based models to test causal roles of candidate regulators.

What Happens During regulation of monocyte differentiation?

Signal perception and signaling modules
In simple terms: The cell first listens to outside signals that tell it whether to differentiate.
Regulation of monocyte differentiation begins with the perception of extracellular cues that are interpreted by specific signaling modules. These modules convert environmental information into intracellular signals that feed into transcription factor networks controlling lineage commitment. Tumor-derived retinoic acid is one such cue that regulates intratumoral monocyte differentiation and can shift cells toward an immunosuppressive program. The identity and wiring of these signaling modules determine the frequency and extent of differentiation.
Transcription factor networks and fate commitment
In simple terms: Inside the nucleus, a set of master regulators decides which cell type the monocyte will become.
Associated transcription factor networks execute the differentiation program downstream of signaling modules. MafB restricts local monocyte proliferation and precedes lung interstitial macrophage differentiation, coupling cell-cycle control to fate. ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment, showing that active repression of alternative fates is a core regulatory mechanism. These factors together determine whether a monocyte adopts a macrophage or dendritic cell trajectory.
Metabolic and membrane regulation
In simple terms: Metabolic and membrane proteins can speed up or slow down the differentiation process.
PAQR11 modulates monocyte-to-macrophage differentiation and is linked to the pathogenesis of rheumatoid arthritis, indicating that membrane-associated metabolic regulators participate in GO:0045655. Such regulators can influence the rate and extent of differentiation and thereby contribute to disease. Their activity is integrated with the transcription factor networks that define lineage commitment.
Non-coding RNA layers
In simple terms: Small RNA molecules fine-tune the timing and strength of differentiation.
Activation-associated microRNA accumulation rates are regulated during monocyte-to-macrophage differentiation, providing a post-transcriptional layer of control. tRNA-derived short non-coding RNAs are profiled during monocyte differentiation and play a role in macrophage survival, linking non-coding RNA biology to the differentiation outcome. These RNA circuits modulate the stability and translation of differentiation-associated transcripts.
Trafficking and antigen-presentation remodeling
In simple terms: The cell also reorganizes its internal transport and surface display systems as it differentiates.
Regulation and trafficking of HLA-E molecules occur during monocyte-macrophage differentiation, connecting the differentiation program to antigen-presentation machinery. This remodeling ensures that the maturing cell can present antigens appropriately once differentiation is complete. It represents a downstream consequence of the signaling and transcriptional changes that define GO:0045655.

Key Genes Involved in GO:0045655 regulation of monocyte differentiation

The following genes and proteins have been experimentally implicated in the regulation of monocyte differentiation (GO:0045655) in the cited literature.
GeneMajor RoleResearch Relevance
MAFBRestricts local monocyte proliferation preceding lung interstitial macrophage differentiationLinks proliferation control to differentiation fate in lung macrophages
ETV3Enables monocyte differentiation into dendritic cells by repressing macrophage fate commitmentTranscription factor controlling dendritic cell versus macrophage fate
ETV6Enables monocyte differentiation into dendritic cells by repressing macrophage fate commitmentTranscription factor controlling dendritic cell versus macrophage fate
PAQR11Modulates monocyte-to-macrophage differentiationImplicated in rheumatoid arthritis pathogenesis
HLA-ERegulated and trafficked during monocyte-macrophage differentiationConnects differentiation to antigen presentation
MicroRNA machinery (activation-associated miRNAs)Regulates activation-associated microRNA accumulation rates during monocyte-to-macrophage differentiationPost-transcriptional control of differentiation
tRNA-derived short non-coding RNAsProfiled during monocyte differentiation; role in macrophage survivalNon-coding RNA layer of differentiation control
Retinoic acid pathway componentsMediate tumor-derived retinoic acid regulation of intratumoral monocyte differentiationTarget for cancer immunotherapy research
Signaling module componentsInterpret extracellular cues into transcription factor network activityCore regulators of differentiation frequency and extent
Transcription factor network componentsExecute lineage-specific gene expression programsCentral to fate commitment
Monocyte differentiation-associated genesCollectively modulate frequency, rate or extent of monocyte differentiationBroad category for CRISPR screening
Macrophage fate commitment genesRepressed by ETV3/ETV6 to allow dendritic cell differentiationFate-switching research
Dendritic cell fate genesPromoted by ETV3/ETV6 during monocyte differentiationDendritic cell generation research
Rheumatoid arthritis-associated monocyte genesContribute to monocyte-to-macrophage differentiation in diseaseAutoimmune disease modeling
Lung interstitial macrophage differentiation genesRegulated by MafB-restricted monocyte proliferationLung macrophage biology
Antigen presentation genesRemodeled during monocyte-macrophage differentiationImmune recognition research
Non-coding RNA host genesGive rise to microRNAs and tRNA-derived short RNAs regulating differentiationNon-coding RNA therapeutics research
Tumor microenvironment-derived factorsRegulate intratumoral monocyte differentiationCancer immunology research

How Is regulation of monocyte differentiation Regulated?

Regulation of monocyte differentiation (GO:0045655) is itself controlled by specific signaling modules and associated transcription factor networks that integrate extracellular cues into lineage-specific gene expression. MafB restricts local monocyte proliferation before lung interstitial macrophage differentiation, showing that cell-cycle regulators are part of the regulatory logic. Tumor-derived retinoic acid acts as an environmental regulator that redirects intratumoral monocyte differentiation toward immune suppression. PAQR11 modulates monocyte-to-macrophage differentiation and disease pathogenesis, adding a metabolic/membrane layer of control. At the post-transcriptional level, activation-associated microRNA accumulation rates and tRNA-derived short non-coding RNAs are regulated during differentiation and influence macrophage survival. HLA-E trafficking is also regulated during monocyte-macrophage differentiation, linking the process to antigen-presentation remodeling.

regulation of monocyte differentiation and Human Disease

GeneDisease / BiologyPotential Experimental Model
PAQR11Rheumatoid arthritisKnockout and overexpression in monocyte cell lines
Retinoic acid pathway componentsTumor immune suppressionTumor-conditioned monocyte differentiation assays
MAFBLung interstitial macrophage differentiationConditional knockout in lung monocyte models
ETV3/ETV6Dendritic cell versus macrophage fateKnockout and rescue in monocyte differentiation cultures
HLA-EAntigen presentation during differentiationTagged knock-in for trafficking studies
Cancer and tumor immune suppression
Tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression, directly linking GO:0045655 to cancer immune evasion. This mechanism shows that the tumor microenvironment can hijack monocyte differentiation to generate immunosuppressive cells. Targeting this regulatory axis is a potential strategy in cancer immunotherapy.
Rheumatoid arthritis and autoimmune disease
PAQR11 modulates monocyte-to-macrophage differentiation and the pathogenesis of rheumatoid arthritis, implicating GO:0045655 in autoimmune joint disease. Dysregulated monocyte differentiation can therefore contribute to chronic inflammation. This makes the regulatory machinery an attractive target for anti-inflammatory intervention.
Lung macrophage biology and tissue homeostasis
MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation, connecting GO:0045655 to lung tissue macrophage homeostasis. Perturbation of this regulatory step could affect lung immune surveillance and repair. Understanding it may inform therapies for lung inflammatory diseases.
Antigen presentation and immune recognition
Regulation and trafficking of HLA-E during monocyte-macrophage differentiation links GO:0045655 to antigen presentation and immune recognition. Altered HLA-E dynamics could affect how differentiated cells interact with NK and T cells. This connection is relevant to transplantation and tumor immunology research.

From regulation of monocyte differentiation-Related Genes to Experimental Models

Research QuestionSuitable Model
Is a candidate gene required for monocyte differentiation?CRISPR knockout in monocyte cell lines or primary monocytes
Does a specific point mutation alter differentiation rate?CRISPR point mutation knock-in
Does a disease-associated variant change differentiation fate?Knock-in of the variant allele
Where and when is a regulator expressed during differentiation?Tagged knock-in (e.g., fluorescent or epitope tag)
Does overexpression of a regulator accelerate or block differentiation?CRISPR overexpression or cDNA overexpression
Which genes modulate monocyte differentiation in a genome-wide manner?CRISPR library screening with differentiation readouts

How to Study the regulation of monocyte differentiation Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal transcriptome changes during differentiationIdentifying transcription factor networks and signaling modules
Small RNA-seqmicroRNA and tRNA-derived short RNA profilesPost-transcriptional regulation of differentiation
Imaging/trafficking assaysLocalization and transport of molecules such as HLA-EAntigen-presentation remodeling during differentiation
Flow cytometrySurface marker expression and differentiation stateQuantifying monocyte-to-macrophage or dendritic cell differentiation
Proliferation assaysLocal monocyte proliferationTesting MafB-restricted proliferation before macrophage differentiation
CRISPR knockoutLoss-of-function effects on differentiationTesting causal roles of candidate regulators
CRISPR overexpressionGain-of-function effects on differentiationTesting whether a regulator accelerates or blocks differentiation
CRISPR library screeningGenome-wide modifiers of differentiationDiscovering new regulators within GO:0045655
Transcriptomic profiling of differentiation
RNA-seq and related transcriptomic methods can capture the gene expression changes that occur as monocytes differentiate, revealing the transcription factor networks and signaling modules that define GO:0045655. Such profiling has been used to characterize activation-associated microRNA accumulation during monocyte-to-macrophage differentiation. It also supports the discovery of non-coding RNA players such as tRNA-derived short RNAs.
Non-coding RNA profiling
Small RNA sequencing and tRNA-derived fragment profiling measure the non-coding RNA layers that regulate monocyte differentiation and macrophage survival. These methods quantify accumulation rates and identify RNAs whose abundance changes with differentiation state. They are essential for understanding post-transcriptional control within GO:0045655.
Protein trafficking and localization assays
Imaging and biochemical trafficking assays can monitor molecules such as HLA-E as they are regulated and transported during monocyte-macrophage differentiation. These approaches reveal how differentiation remodels intracellular transport and surface presentation. They complement transcriptional and non-coding RNA studies.
Functional perturbation assays
Knockout, knockdown, overexpression and pharmacological perturbation are used to test whether candidate regulators such as PAQR11, MafB, ETV3 or ETV6 causally affect monocyte differentiation. Differentiation readouts can include surface marker expression, morphology and proliferation. These assays connect molecular regulators to the frequency and extent of differentiation defined by GO:0045655.

How CRISPR Can Be Used to Study GO:0045655 regulation of monocyte differentiation

Knockout

CRISPR knockout is used to delete candidate regulators of monocyte differentiation and test whether they are required for the process. For example, knocking out factors such as PAQR11, MafB, ETV3 or ETV6 can reveal their contribution to monocyte-to-macrophage or dendritic cell differentiation. Knockout models are foundational for assigning causal roles within GO:0045655.

Point Mutation

CRISPR point mutation introduces precise nucleotide changes to model disease-associated variants or to dissect functional domains of regulators. This approach can determine whether a specific residue or variant alters the frequency or extent of monocyte differentiation. It is particularly useful when complete knockout is lethal or when a subtle regulatory change is suspected.

Knock-in

CRISPR knock-in can insert tags, reporters or disease alleles at endogenous loci to study regulation of monocyte differentiation in a physiological context. Tagged knock-in of genes such as HLA-E enables tracking of protein trafficking during differentiation. Knock-in of variants can model how specific alleles affect differentiation fate.

Overexpression

CRISPR overexpression or cDNA overexpression is used to test whether increased levels of a regulator accelerate, block or redirect monocyte differentiation. Overexpressing factors such as ETV3 or ETV6 can probe their ability to repress macrophage fate and promote dendritic cell differentiation. Overexpression studies complement loss-of-function approaches to build a complete regulatory picture of GO:0045655.

How EDITGENE Supports regulation of monocyte differentiation Research

Researchers studying regulation of monocyte differentiation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides the CRISPR cell model and screening services needed to move from candidate lists to functional evidence within GO:0045655.
Contact EDITGENE today to design your custom CRISPR model for regulation of monocyte differentiation research.

Frequently Asked Questions About regulation of monocyte differentiation

GO:0045655 is a Gene Ontology biological_process term defined as any process that modulates the frequency, rate or extent of monocyte differentiation.
Genes and proteins experimentally implicated include MAFB, ETV3, ETV6, PAQR11 and HLA-E, as well as non-coding RNA players such as microRNAs and tRNA-derived short RNAs.
Specific transcription factor networks execute the differentiation program, with MafB restricting proliferation before macrophage differentiation and ETV3/ETV6 repressing macrophage fate to enable dendritic cell differentiation.
Yes, tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression.
PAQR11 modulates monocyte-to-macrophage differentiation and the pathogenesis of rheumatoid arthritis.
Activation-associated microRNA accumulation rates are regulated during monocyte-to-macrophage differentiation, providing post-transcriptional control.
They are profiled during monocyte differentiation and play a role in macrophage survival.
HLA-E molecules are regulated and trafficked during monocyte-macrophage differentiation, linking the process to antigen presentation.
Common methods include RNA-seq, small RNA-seq, imaging/trafficking assays, flow cytometry, proliferation assays and CRISPR perturbation.
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of candidate regulators, and CRISPR library screening enables genome-wide discovery within GO:0045655.

Conclusion

GO:0045655 (regulation of monocyte differentiation) is a biologically_process term that captures the signaling modules, transcription factor networks, metabolic regulators and non-coding RNA circuits controlling monocyte fate. Its relevance spans cancer immune suppression, rheumatoid arthritis, lung macrophage biology and antigen presentation. CRISPR-based cell models and screening provide a direct route to test causal roles of candidate regulators and to discover new nodes within this process.

References

  1. 1. Huber R et al.. 2014. Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.. Cell Mol Life Sci 71(1):63-92 PMID: 23525665
  2. 2. Vanneste D et al.. 2023. MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation.. Nat Immunol 24(5):827-840 PMID: 36928411
  3. 3. Devalaraja S et al.. 2020. Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression.. Cell 180(6):1098-1114.e16 PMID: 32169218
  4. 4. Lin Y et al.. 2021. PAQR11 modulates monocyte-to-macrophage differentiation and pathogenesis of rheumatoid arthritis.. Immunology 163(1):60-73 PMID: 33421113
  5. 5. Camilli G et al.. 2016. Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation.. J Leukoc Biol 99(1):121-30 PMID: 26310830
  6. 6. Eigsti RL et al.. 2014. Regulation of activation-associated microRNA accumulation rates during monocyte-to-macrophage differentiation.. J Biol Chem 289(41):28433-47 PMID: 25148686
  7. 7. Jayaram A et al.. 2025. Profile of tRNA-derived short non-coding RNAs during monocyte differentiation and their role in macrophage survival.. RNA Biol 22(1):1-9 PMID: 40575931
  8. 8. Villar J et al.. 2023. ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment.. Nat Immunol 24(1):84-95 PMID: 36543959
Contact Us
*
*
*
*
How did you hear about us: